Augmedics, a Chicago, IL-based augmented reality (AR) surgical navigation company, raised $82.5M in Series D funding.
The round was led by CPMG with participation from Evidity Health Capital and current investors H.I.G. Capital, Revival Healthcare Capital, Almeda Ventures and others. CMPG’s Kent McGaughy and Evidity’s Paul Enever will join Augmedics’ board of directors.
The company intends to use the funds to expand its US commercial presence as well as the delivery of its platform advancements which will enable mass-scale adoption of the xvision technology.
Led by President and CEO Kevin Hykes, Augmedics focuses on augmented reality technologies to improve surgical outcomes. Its xvision Spine System allows surgeons to see patients’ anatomy as if they have “x-ray vision” and accurately navigate instruments and implants during spine procedures. The FDA-cleared xvision has been used to treat over 4,000 patients and implant more than 20,000 pedicle screws across 21 US states.
FinSMEs
27/06/2023